This early-stage study tests a new drug called OLX-07010 in healthy adults and elderly volunteers to see if it is safe and how the body processes it. The drug aims to stop harmful tau proteins from clumping together, which is linked to Alzheimer's disease. 88 participants will re…
Phase: PHASE1 • Sponsor: Oligomerix, Inc • Aim: Disease control
Last updated May 26, 2026 10:22 UTC